この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2014/3/101 分で読めます
MK Laboratories, Inc., et al.; Proposal To Withdraw Approval of Three Abbreviated New Drug Applications for Propoxyphene Products; Opportunity for a Hearing
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) is proposing to withdraw approval of three abbreviated new drug applications (ANDAs) for propoxyphene drug products from multiple sources and is announcing an opportunity for holders of those ANDAs to request a hearing on this proposal.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →